Tears may reveal best glaucoma treatment
NCT ID NCT07592988
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines tear fluid for signs of inflammation in people with glaucoma who receive different treatments. Researchers will measure certain proteins in tears and eye pressure before and after treatment. The goal is to see if these tear markers can predict how well a treatment works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors choose the best glaucoma treatment based on tear fluid markers.
- What could go wrong
- This is a small, early study with only 24 participants, so results may not apply to everyone. It is designed to gather knowledge, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kazakh Eye Research Institute
RECRUITINGAlmaty, 050012, Kazakhstan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Could your personality predict glaucoma drug side effects?
- Could a single eye implant replace years of glaucoma drops?